Company Filing History:
Years Active: 2004-2006
Title: Brian L Kelsall: Innovator in Medical Treatments
Introduction
Brian L Kelsall is a notable inventor based in Washington, DC, who has made significant contributions to the field of medical treatments. He holds two patents that focus on innovative methods for treating inflammatory bowel disease and enhancing immune responses.
Latest Patents
Kelsall's latest patents include methods of treating inflammatory bowel disease using cholera toxin B subunit. This invention provides a method for treating or preventing inflammation in a subject by administering an effective amount of cholera toxin subunit B. Additionally, it offers a method for decreasing the activity of interferon gamma and IL-12 in a subject, also through the administration of cholera toxin subunit B. Furthermore, Kelsall's invention includes a method for treating or preventing Th1 T-cell mediated autoimmune disorders using the same cholera toxin subunit B. Another significant patent focuses on inducing an antigen-specific, mucosal cytotoxic T lymphocyte response, which is useful in preventing and treating infections with pathogens that enter through mucosal surfaces.
Career Highlights
Brian L Kelsall is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore and develop groundbreaking medical treatments that have the potential to improve patient outcomes.
Collaborations
Kelsall has collaborated with esteemed colleagues such as Jay A Berzofsky and Igor Belyakov, contributing to a rich environment of innovation and research.
Conclusion
Brian L Kelsall's contributions to medical science through his patents demonstrate his commitment to advancing healthcare solutions. His work continues to impact the field positively, showcasing the importance of innovation in medicine.